STXS
Stereotaxis Inc
Price:  
1.83 
USD
Volume:  
348,729.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

STXS EV/EBITDA

-339.9%
Upside

As of 2025-03-15, the EV/EBITDA ratio of Stereotaxis Inc (STXS) is -6.77. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STXS's latest enterprise value is 145.47 mil USD. STXS's TTM EBITDA according to its financial statements is -21.49 mil USD. Dividing these 2 quantities gives us the above STXS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 16.0x - 21.6x 18.8x
Forward P/E multiples 13.9x - 20.2x 17.0x
Fair Price (3.91) - (4.96) (4.39)
Upside -313.4% - -371.2% -339.9%
1.83 USD
Stock Price
(4.39) USD
Fair Price

STXS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-03-03 -7.21
2025-02-28 -7.68
2025-02-27 -8.12
2025-02-26 -8.36
2025-02-25 -8.12
2025-02-24 -8.56
2025-02-21 -8.20
2025-02-20 -8.59
2025-02-19 -8.52
2025-02-18 -8.12
2025-02-14 -8.48
2025-02-13 -8.52
2025-02-12 -8.04
2025-02-11 -8.83
2025-02-10 -9.03
2025-02-07 -9.15
2025-02-06 -9.19
2025-02-05 -9.67
2025-02-04 -9.35
2025-02-03 -8.91
2025-01-31 -9.11
2025-01-30 -8.91
2025-01-29 -8.44
2025-01-28 -8.63
2025-01-27 -8.67
2025-01-24 -8.20
2025-01-23 -8.28
2025-01-22 -8.20
2025-01-21 -8.12
2025-01-17 -7.76
2025-01-16 -7.84
2025-01-15 -7.92
2025-01-14 -7.72
2025-01-13 -7.76
2025-01-10 -7.88
2025-01-08 -8.32
2025-01-07 -8.99
2025-01-06 -9.98
2025-01-03 -8.91
2025-01-02 -8.59
2024-12-31 -8.56
2024-12-30 -8.71
2024-12-27 -8.59
2024-12-26 -9.31
2024-12-24 -8.79
2024-12-23 -8.83
2024-12-20 -8.83
2024-12-19 -8.32
2024-12-18 -8.48
2024-12-17 -8.91